High incidence of germline BRCA mutation in patients with ER low‐positive/PR low‐positive/HER‐2 neu negative tumors

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|19|3422-3427

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.19, 2015-10, pp. : 3422-3427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low Incidence of Germline BRCA2 Gene Mutations among Spanish Breast Cancer Patients

By  

Oncology, Vol. 57, Iss. 2, 1999-08 ,pp. : 173-174

Karger

Access to resources Recommend Favorite

Change in HER-2/neu Status from Negative to Positive following Treatment in Breast Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-01 ,pp. : 19-24

Karger

Access to resources Recommend Favorite

Impact of neoadjuvant chemotherapy on pathologic axillary nodal status in HER‐2 positive patients presenting with clinically node‐negative disease

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 5, 2015-12 ,pp. : 453-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer

By  

Oncology, Vol. 88, Iss. 6, 2015-0 ,pp. : 377-384

Karger

Access to resources Recommend Favorite

Concomitant Oral and Intravenous Pharmacokinetics of Dabrafenib, a BRAF Inhibitor, in Patients with BRAF V600 Mutation‐Positive Solid Tumors

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 53, Iss. 9, 2013-09 ,pp. : 955-961

John Wiley & Sons Inc

Access to resources Recommend Favorite